As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
-
-
Systemic recurrence of endometrial cancer more than 10 years after hysterectomy: a report of two cases and a brief review of the literature
-
Pitfalls in scientific research: critical appraisal of articles published in one of the international journals in Egypt
-
Primary urethral small cell melanoma with neuroendocrine differentiation: a case report
-
Relation between GSTP1 polymorphism and oxidative stress in patients with hepatocellular carcinoma
-
Primary desmoplastic small-round-cell tumor of the ovary
-
Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center
-
Vulvar cancer: surgical management and survival trends in a low resource setting
-
Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
-
Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial
About the Editor
Heba Moussa, MD.
Department of Clinical Pathology, National Cancer Institute, Cairo University, Egypt.
Aims and scope
As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.
About the Society
Journal of the Egyptian National Cancer Institute is the official journal of the National Cancer Institute, Cairo University, accomplishing high quality research in its respected field.
Official journal of
-
Journal of the Egyptian National Cancer Institute is the official journal of the National Cancer Institute, Egypt.
Citation Impact
0.94 - CiteScore
0.541 - SNIP (Source-Normalized Impact per Paper)
0.334 - SJR (SCImago Journal Rank)
- ISSN: 2589-0409 (electronic)
